Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
novartis
3
×
bill cassidy
biogen
biotech
boulder/denver blog main
boulder/denver top stories
cancer
celgene
detroit blog main
detroit top stories
gene therapy
hemophilia
indiana blog main
indiana top stories
ipo
johnson & johnson
mark warner
medicaid
medicare
meiragtx
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
spinal muscular atrophy
texas blog main
What
gene
3
×
bio
roundup
therapy
age
alzheimer’s
becker
bigger
biggest
billions
come
companies
deal
different
dollars
drug
eaton
emerging
fail
gave
healthcare
impact
increases
j
johnson
latest
life
meiragtx
michael
millions
morning
moves
past
patients
pharmaceutical
plan
prescription
price
prices
raise
Language
Current search:
novartis
×
gene
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy